Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Biotech
Skye and Redx combine with $125M to advance fibrosis assets
Skye Bioscience and Redx Pharma have combined in a deal that will net $125 million in financing for the new public company, called Fibrx Therapeutics.
Will Maddox
Aug 14, 2026 2:05pm
Jazz pays $820M to add epilepsy-focused Actio to its orchestra
Aug 10, 2026 10:40am
KKR inks $5.7B deal to take medtech manufacturer Integer private
Aug 4, 2026 9:09am
Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal
Jul 21, 2026 1:26pm
Fierce Pharma
Vertex to pay $10B for Crinetics in its largest-ever deal
Jul 7, 2026 8:08am
Zimmer Biomet buys pain relief system from Pacira in $140M deal
Jul 1, 2026 10:58am
